Anticonvulsant action of 1,3-dimethyl-5-aminoadamantane

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Naunyn-Schmiedeberg's Archives of Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF00633204PMID 3951570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The reduction of excitability of the γ-loop by 1,3-dimethyl-5-aminoadamantane (DMAA)

  2004cited by this paper
• The depression of monosynaptically excited α-motoneurons during vibration reflex by dimethylaminoadamantan (DMAA)

  2004cited by this paper
• The influence of memantine on the anticonvulsant effects of the antiepileptic drugs.

  1983cited by this paper
• Inhibition of sympathetic neurotransmission in the rat anococcygeus muscle by diazepam

  1983cited by this paper
• [Memantine and neurogenic bladder disorders within the bounds of spastic conditions].

  1982cited by this paper
• Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid.

  1982cited by this paper
• [Valve of symptomatic therapy with memantine in cerebral coma. II. Development of stretch synergisms in coma with brain stem symptoms].

  1982cited by this paper
• [The Effect of memantine on spinal alpha-motoneurons and on the content of dopamine, noradrenaline and serotonin in the striatum and lumbar spinal cord].

  1982cited by this paper
• [Valve of symptomatic therapy with memantine in cerebral coma. I. Correlation with coma stages and EEG spectral patterns].

  1982cited by this paper
• [Effect of memantine on membrane properties and postsynaptic potentials in neurons of Aplysia californica].

  1982cited by this paper
• Valve of symptomatic therapy with memantine in cerebral coma. I. Correlation with coma stages and EEG spectral patterns

  1982cited by this paper
• Valve of symptomatic therapy with memantine in cerebral coma. II. Development of stretch synergisms in coma with brain stem symptoms

  1982cited by this paper
• Effect of memantine on membrane properties and postsynaptic potentials in neurons of Aplysia californica

  1982cited by this paper
• The effect of memantine on various neurobiological processes.

  1982cited by this paper
• [Effect of memantine on central neurotransmitter systems. Review of the results].

  1982cited by this paper
• Effect of Dopaminergic and GABA‐ergic Drugs Given Alone or in Combination on the Anticonvulsant Action of Phenobarbital and Diphenylhydantoin in the Electroshock Test in Mice

  1980cited by this paper
• Brain dopamine and seizure susceptibility in mice.

  1978cited by this paper
• [Effects of intravenous administration of memantine in parkinsonian patients (author's transl)].

  1977cited by this paper
• The effect of dimethylaminoadamantane on neuronal membranes.

  1976cited by this paper
• Neuropharmacological studies on D145 (1,3-dimethyl-5-aminoadamantan)

  1975cited by this paper
• Photically induced epilepsy in Papio papio as a model for drug studies.

  1975cited by this paper
• The reduction of excitability of the gamma-loop by 1,3-dimethyl-5-aminoadamantane (DMAA).

  1974cited by this paper
• Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.

  1974cited by this paper
• Dopamine release and direct dopamine receptor activation in the central nervous system by D-145, an amantadine derivative.

  1973cited by this paper
• Decrease of muscle rigidity by dimethylaminoadamantan (DMMA) in intercollicularly decerebrated cats.

  1973cited by this paper
• Effects of L-tryptophan, L-3, 4, dihydroxyphenylalanine and tranylcypromine on the electroencephalogram and on photically induced epilepsy in the baboon, Papio papio.

  1972cited by this paper
• The effects of apomorphine, (+)‐amphetamine and l‐dopa on maximal electroshock convulsions—a comparative study in the rat and mouse

  1972cited by this paper
• Convulsive effects of 4-deoxypyridoxine and of bicuculline in photosensitive baboons (Papio papio) and in rhesus monkeys (Macaca mulatta).

  1971cited by this paper
• [Amantadine in the treatment of Parkinson's disease].

  1970cited by this paper
• Amantadine in the treatment of Parkinson's disease.

  1969cited by this paper
• Comparative assays of antiepileptic drugs in mice and rats.

  1952cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• Does Alzheimer's disease with mesial temporal lobe epilepsy represent a distinct disease subtype?

  2023cites this paper
• Fenfluramine diminishes NMDA receptor-mediated seizures via its mixed activity at serotonin 5HT2A and type 1 sigma receptors

  2018cites this paper
• Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction

  2016cites this paper
• Glutamate Receptors as Targets for Novel Antiepileptic Drug Therapy

  2016cites this paper
• Effect of Verapamil, Cinnarizine and Memantine on Maximal Electroshock, Picrotoxin, and Pilocarpine-Induced Seizure Models in Albino Mice

  2015cites this paper
• N‐methyl‐D‐aspartate receptor channel blockers prevent pentylenetetrazole‐induced convulsions and morphological changes in rat brain neurons

  2015cites this paper
• Targeting NMDA Receptors in Epilepsy

  2014cites this paper
• Synaptic plasticity in glutamatergic and GABAergic neurotransmission following chronic memantine treatment in an in vitro model of limbic epileptogenesis.

  2014cites this paper
• Modulation of NMDA Receptor Activity During Physiological and Pathophysiological Events

  2014cites this paper
• The effect of combined treatment of alpha-tocopherol, ascorbic acid, and pyridoxine with NMDA blocker memantine on penicillin-induced epileptiform activity in rats

  2013cites this paper
• The effect of co-administration of the NMDA blocker with agonist and antagonist of CB1-receptor on penicillin-induced epileptiform activity in rats.

  2011cites this paper
• The NMDA receptor complex as a therapeutic target in epilepsy: a review.

  2011cites this paper
• Memantine reduces mania-like symptoms in animal models.

  2011cites this paper
• Differential Alterations in Excitatory and Inhibitory Networks Involving Dentate Granule Cells Following Chronic Treatment with Distinct Classes of NMDAR Antagonists in Hippocampal Slice Cultures

  2010cites this paper
• Different effects of two N-methyl-D-aspartate receptor antagonists on seizures, spontaneous behavior, and motor performance in immature rats.

  2009cites this paper
• Laparophobia: a cognitive perspective on appetite control in anorexia nervosa

  2005cites this paper
• MANAGEMENT OF CONVULSIONS IN NERVE AGENT ACUTE POISONING: A POLISH PERSPECTIVE

  2004cites this paper
• Sodium channels and epilepsy electrophysiology.

  2002cites this paper
• Atypical Antipsychotics and Serotoninergic Antidepressants in Patients with Epilepsy: Pharmacodynamic Considerations

  2002cites this paper
• Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.

  2001cites this paper
• Memantine is a clinically well tolerated N-methyl-D-aspartate (NMDA) receptor antagonist--a review of preclinical data.

  1999cites this paper
• Saving the nerve from glaucoma: memantine to caspaces.

  1999cites this paper
• Protective Effects of Memantine Against Ischemia-Reperfusion Injury in Spontaneously Hypertensive Rats

  1999cites this paper
• Clinically available NMDA antagonist, memantine, attenuates tolerance to analgesic effects of morphine in a mouse tail flick test.

  1999cites this paper
• Mechanism of memantine block of NMDA‐activated channels in rat retinal ganglion cells: uncompetitive antagonism.

  1997cites this paper
• Effects of N-methyl-D-aspartate receptor antagonists on cisplatin-induced emesis in the ferret.

  1996cites this paper
• The role of dopamine in epilepsy

  1996cites this paper
• Comparison of the potency, kinetics and voltage-dependency of a series of uncompetitive NMDA receptor antagonists in vitro with anticonvulsive and motor impairment activity in vivo.

  1995cites this paper
• Chronic treatment with the uncompetitive NMDA receptor antagonist memantine influences the polyamine and glycine binding sites of the NMDA receptor complex in aged rats

  1995cites this paper
• Anticonvulsant effects of memantine and MK-801 in guinea pig hippocampal slices.

  1995cites this paper
• Alterations in monoamine levels in discrete regions of rat brain after chronic administration of carbamazepine

  1994cites this paper
• Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines.

  1993cites this paper
• Memantine stimulates inositol phosphates production in neurones and nullifies N-methyl-D-aspartate-induced destruction of retinal neurones.

  1992cites this paper
• Antiparkinsonian drugs memantine and trihexyphenidyl potentiate the anticonvulsant activity of valproate against maximal electroshock-induced seizures.

  1992cites this paper
• Open-channel block of N-methyl-D-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity

  1992cites this paper
• The role of mesencephalic and thalamic arousal systems in experimental seizures.

  1992cites this paper
• The NMDA Receptor, NMDA Antagonists and Epilepsy Therapy

  1992cites this paper
• Kindled rats are more sensitive than non-kindled rats to the behavioural effects of combined treatment with MK-801 and valproate.

  1992cites this paper
• Prophylactic and therapeutic efficacy of memantine against seizures produced by soman in the rat.

  1992cites this paper
• Effects of the 1-amino-adamantanes at the MK-801-binding site of the NMDA-receptor-gated ion channel: a human postmortem brain study.

  1991cites this paper
• Inhibition by thyrotropin-releasing hormone of epileptic seizures in spontaneously epileptic rats.

  1991cites this paper
• The novel competitive N-methyl-D-aspartate (NMDA) antagonist CGP 37849 preferentially induces phencyclidine-like behavioral effects in kindled rats: attenuation by manipulation of dopamine, alpha-1 and serotonin1A receptors.

  1991cites this paper
• Modulation of glycine-activated membrane current by adamantane derivatives.

  1991cites this paper
• Responses to NMDA receptor antagonists altered by epileptogenesis.

  1991cites this paper
• Seizure promotion and protection by D-1 and D-2 dopaminergic drugs in the mouse.

  1990cites this paper
• High doses of memantine (1-amino-3,5-dimethyladamantane) induce seizures in kindled but not in non-kindled rats

  1990cites this paper
• Memantine reduces repetitive action potential firing in spinal cord nerve cell cultures.

  1990cites this paper
• Memantine displaces [3H]MK-801 at therapeutic concentrations in postmortem human frontal cortex.

  1989cites this paper
• Memantine inhibits serotonin-induced rise of cytosolic Ca2+ activity and of cyclic GMP level in a neuronal cell line.

  1989cites this paper
• Amantadine: a new clinical profile for traumatic brain injury.

  1989cites this paper
• Toxins from the venom of the green mamba Dendroaspis angusticeps that inhibit the binding of quinuclidinyl benzilate to muscarinic acetylcholine receptors.

  1988cites this paper
• Dopamine-sensitive anticonvulsant site in the rat striatum

  1988cites this paper
• Memantine (1-amino-3,5-dimethyladamantane) blocks the serotonin-induced depolarization response in a neuronal cell line.

  1988cites this paper
• The role of the brain stem in generalized epileptic seizures

  1987cites this paper
• In vitro electrophysiological evidence predicting anticonvulsant efficacy of memantine and flunarizine.

  1987cites this paper